(Q34192100)

31 July 2017

1 reference

title

Anaphylaxis: mechanisms and management (English)

1 reference

31 July 2017

1 reference

1 reference

J K Lee

1

1 reference

31 July 2017

P Vadas

series ordinal

2

1 reference

31 July 2017

publication date

1 July 2011

1 reference

Clinical & Experimental Allergy

31 July 2017

published in

1 reference

31 July 2017

volume

41

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

923-938

1 reference

A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Further Experiences with Severe Allergic Reactions to Insect Stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Clinical features and severity grading of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylaxis. A review of 266 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Diagnostic approaches to the patient with suspected food allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Time trends in allergic disorders in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylaxis fatalities and admissions in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Hypersensitivity to antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Rapid desensitization of hypersensitivity reactions to chemotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Classification and pathophysiology of radiocontrast media hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Epidemiology of Hymenoptera allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Epidemiology of insect-venom anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Multicenter study of emergency department visits for insect sting allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

A population-based epidemiologic analysis of deaths from anaphylaxis in Florida.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Factors associated with repeated use of epinephrine for the treatment of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Peanut and tree nut allergic reactions in restaurants and other food establishments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Allergy-like reactions to iodinated contrast agents. A critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Contaminated heparin associated with adverse clinical events and activation of the contact system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Prevalence and titer of IgE antibodies to mouse allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

A case of cold-dependent exercise-induced anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Atopy and anaphylactic reactions to suxamethonium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992-94)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Gender risk for anaphylactoid reaction to radiographic contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Safety and efficacy of adalimumab in pediatric patients with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Monoamine oxidase inhibitor update. Potential adverse food and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Further fatalities caused by anaphylactic reactions to food, 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Fatalities due to anaphylactic reactions to foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Lessons for management of anaphylaxis from a study of fatal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

The natural history of peanut allergy in young children and its association with serum peanut-specific IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Food allergy and asthma--what is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Further fatal allergic reactions to food in the United Kingdom, 1999-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Late-onset allergic reactions, including serum sickness, after insect stings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

5. IgE, mast cells, basophils, and eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Molecular regulation of mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Identification of basophils by a mAb directed against pro-major basic protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Activation of human mast cells through the platelet-activating factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Managing acute collapse in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Severe allergy in a pregnant woman after vaginal examination with a latex glove

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylactic reactions during surgical and medical procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylaxis during surgical and interventional procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

How much specific is the association between hymenoptera venom allergy and mastocytosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Biphasic anaphylactic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Can serum mast cell tryptase help diagnose anaphylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Diagnostic value of tryptase in anaphylaxis and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Tryptase is not cleared by the kidneys into the urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

21 January 2018

Update on food allergy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Utility of food-specific IgE concentrations in predicting symptomatic food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Advances in H1-antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Adrenaline is first line treatment for the emergency treatment of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Management of anaphylaxis in the emergency setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Emergency treatment of anaphylactic reactions--guidelines for healthcare providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Serious shortcomings in the management of children with anaphylaxis in Scottish schools

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Human cardiac mast cells in anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Cardiovascular disease and anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Management protocol for anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Successful treatment of severe anaphylactic shock with vasopressin. Two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anti-IgE as a mast cell-stabilizing therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylactic shock depends on PI3K and eNOS-derived NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylactic reaction to patent blue V after sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Severe anaphylactic shock with methylene blue instillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylactic reaction to methylene blue dye after laparoscopic chromopertubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Outcomes of a natural rubber latex control program in an Ontario teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

21 January 2018

Insect sting anaphylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Insect sting allergy and venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Rapid desensitization for hypersensitivity reactions to medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Anaphylaxis to husband's seminal plasma and treatment by local desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

The approach to conception for women with seminal plasma protein hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

National study of US emergency department visits for acute allergic reactions, 1993 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Multicenter study of emergency department visits for food allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Clinical and entomological factors influence the outcome of sting challenge studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

Epidemiology of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03779.X

10.1111/J.1365-2222.2011.03779.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference